Treatment of Perianal Crohn Disease Fistulae

por Osterman, Mark T., Lichtenstein, Gary R.
Publicado 2008

Clozapine-induced acute gastrointestinal necrosis: a case report

por Osterman, Mark T., Foley, Caitlin, Matthias, Isaac
Publicado 2017

Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies

por Dulai, Parambir S., Osterman, Mark T., Lasch, Karen, Cao, Charlie, Riaz, Faisal, Sandborn, William J.
Publicado 2019

Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation

por Osterman, Mark T., Rosario, Maria, Lasch, Karen, Barocas, Morris, Wilbur, Jayson D., Dirks, Nathanael L., Gastonguay, Marc R.
Publicado 2019

Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases

por Yarur, Andres J., Deepak, Parakkal, Vande Casteele, Niels, Battat, Robert, Jain, Anjali, Okada, Lauren, Osterman, Mark, Regueiro, Miguel
Publicado 2020

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

por Lewis, James D, Scott, Frank I, Brensinger, Colleen M, Roy, Jason A, Osterman, Mark T, Mamtani, Ronac, Bewtra, Meenakshi, Chen, Lang, Yun, Huifeng, Xie, Fenglong, Curtis, Jeffrey R
Publicado 2018

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease

por Vaughn, Byron P., Yarur, Andres J., Graziano, Elliot, Campbell, James P., Bhattacharya, Abhik, Lee, Jennifer Y., Gheysens, Katherine, Papamichael, Konstantinos, Osterman, Mark T., Cheifetz, Adam S., Cross, Raymond K.
Publicado 2020